COVID-19 vaccine with an efficacy of 90% is in its final stages of getting approval from the U.S. government.

Moderna and Pfizer's COVID-19 vaccines have shown 90% efficacy during first interim trials and are in the process of getting approval from the FDA.

Moderna and Pfizer's COVID-19 vaccines have shown 90% efficacy during first interim trials and are in the process of getting approval from the FDA.Both Pfizer and Moderna Inc announced that their vaccine is 90% effective based on the first interim analyses of large clinical studies. It is more than the threshold that the FDA has set for its consideration. The results indicate the vaccines induced the kind of immune response that protects people if they were exposed to the coronavirus. Both the Moderna and Pfizer vaccines use the same technology based on a molecule known as mRNA or messenger RNA.

Pfizer has already submitted the request to FDA for emergency use authorization (EUA). The approval would allow the companies to distribute the vaccine immediately during the pandemic. In contrast, Moderna has said it will gather safety data before submitting the request, which may happen in the coming weeks. Further, the U.S. FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec 10 to take a call on the same after discussing with the scientific and public health experts.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.